CACI INTERNATIONAL INC /DE/ 8-K

What Happened

• On March 9, 2026, CACI International Inc. filed an 8-K reporting the closing of its acquisition of ARKA Group, L.P. and the entry into Amendment No. 1 to its Term Loan B Credit Agreement. The purchaser was CACI, Inc. - Federal (a CACI subsidiary) under a Purchase Agreement dated December 19, 2025. The aggregate cash purchase price was $2.6 billion, subject to customary post-closing working capital and related adjustments.
• To help finance the transaction, CACI and certain subsidiaries added an $800 million incremental tranche of term loans (the Incremental Term B-2 Loans) under the existing Term Loan B Credit Agreement. The new tranche matures on March 9, 2033 and carries a floating interest rate tied to either a base rate or Term SOFR plus an applicable margin.

Key Details

• Acquisition closing date: March 9, 2026; purchase price: $2.6 billion in cash (subject to post-closing adjustments).
• Incremental Term B-2 Loans: $800 million; maturity March 9, 2033; floating rate (base rate or Term SOFR + margin).
• Use of proceeds: finance the ARKA acquisition, plus borrowings under the revolver and cash on hand to pay fees and expenses.
• Security and covenants: the Incremental Term B-2 Loans are secured by substantially all assets of CACI and its material domestic subsidiaries and guaranteed by material domestic subsidiaries, and are subject to the same negative covenants as the existing Term Loan B Credit Agreement.

Why It Matters

• The filing confirms CACI has closed a material acquisition (ARKA) that increases the company’s cash-paid purchase obligations by $2.6B and has increased secured senior debt by $800M under the Term Loan B facility. These changes affect CACI’s capital structure, leverage and debt maturities (notably a new tranche maturing in 2033).
• Investors should note the financing mix (incremental term loan, revolver borrowings and cash) and that the new loan carries customary collateral and covenants consistent with the existing credit agreement, which may constrain certain corporate actions while the debt remains outstanding.